TGFB1 and colorectal carcinoma: Normal colon organoids, adenoma‐derived organoids, as well as genetically engineered BRAFV600E organoids, displayed phenotypic and transcriptional changes, indicating a critical importance of TGF‐β already in precursor lesions directing specific adenoma subtypes to the aggressive mesenchymal CMS4 CRC subtype [55].